Basket | Login


Mercè Boada (Spain)

Neurologist (Universitat de Barcelona, 1972). PhD in 1993. Founder and medical director of Fundació ACE 1995. Distinguish professor of Universitat Internacional de Catalunya. Former President of the Catalan Society of Neurology (2000-2002).

Research Interest: Alzheimer's disease and related dementias, including diagnosis, pharmacologic and non-pharmacologic treatment and basic, social, bioethical and legal research applied to the welfare and protection of people suffering dementia and their caregivers.

From 1996 to 2001, advisor on the bioethics committee of the Catalan Government, technical coordinator for the design of care model for people with cognitive impairment, and President of the committee for the Pharmacological Treatment for Alzheimer’s disease of the Catalan Government (CATMA). Co director Documento Sitges 1st and 2nd edition.

Member of the Executive Committee of the European Alzheimer’s Disease Consortium (EADC) and Member of European Institute of Womens Health (EIWH) Advisory Board.

Leader of several projects funded by the Spanish and Catalan Governments, European Union and private institutions: AES, H2020, EFSD, ERA-NET, IMI2, Fundació La Caixa, and Grifols.

To date, leader of more than 110 clinical trials as well as authorship of more than 220 articles, 36 book chapters and 12 books of medical outreach.

Among other awards, recipient of the Professional Excellence Award by the Medical Council of Catalonia (2008); the Josep Trueta Medal for Health Merit, from the Generalitat de Catalunya (2012); the highest honor conferred by the Catalan Government, the “Creu de Sant Jordi” (St. George’s Cross) for her work in the field of Alzheimer’s disease (2014), and Honorable Member of the Spanish Society of Neurology.



Last Updated: Friday 20 July 2018